• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Introduction to 4-Amino-5-chloro-2-methoxybenzoic acid (CAS No. 7206-70-4)

4-Amino-5-chloro-2-methoxybenzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 7206-70-4, is a versatile organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the class of benzoic acid derivatives, characterized by its amino, chloro, and methoxy substituents, which endow it with unique chemical properties and biological activities. The structural features of this molecule make it a valuable scaffold for the development of novel therapeutic agents, particularly in the context of targeting various diseases and disorders.

The benzoic acid core is a well-documented pharmacophore in medicinal chemistry, known for its broad spectrum of biological interactions. The presence of an amino group at the 4-position enhances the compound's solubility and reactivity, while the chloro group at the 5-position introduces electronic and steric effects that can modulate binding affinity to biological targets. Additionally, the methoxy group at the 2-position further diversifies its pharmacological profile. These structural elements collectively contribute to the compound's potential as a lead molecule in drug discovery.

In recent years, 4-Amino-5-chloro-2-methoxybenzoic acid has been extensively studied for its pharmacological properties. One of the most promising areas of research involves its application in anti-inflammatory and immunomodulatory therapies. Studies have demonstrated that derivatives of this compound can interact with various inflammatory pathways, potentially offering therapeutic benefits in conditions such as rheumatoid arthritis and inflammatory bowel disease. The amino and chloro substituents play a crucial role in modulating these interactions, making this compound a attractive candidate for further development.

Furthermore, research has highlighted the compound's potential in anticancer applications. The unique structural motifs present in 4-Amino-5-chloro-2-methoxybenzoic acid allow it to interfere with key signaling pathways involved in cancer cell proliferation and survival. Specifically, studies suggest that this compound can inhibit enzymes such as tyrosine kinases and cyclin-dependent kinases, which are critical for cancer cell growth. The chloro and methoxy groups are particularly important in these interactions, contributing to the compound's ability to disrupt cancer-related signaling networks.

Another area of interest is the antimicrobial activity of 4-Amino-5-chloro-2-methoxybenzoic acid. Emerging evidence indicates that this compound can exhibit potent activity against a range of bacterial and fungal pathogens. The structural features of the molecule enable it to disrupt microbial cell membranes and inhibit essential metabolic processes. This makes it a promising candidate for developing new antimicrobial agents, especially in light of the growing problem of antibiotic resistance.

The synthesis of 4-Amino-5-chloro-2-methoxybenzoic acid is another critical aspect that has been thoroughly investigated. Various synthetic routes have been developed, each with its own advantages and limitations. Common methodologies include direct functionalization of benzoic acid derivatives using chlorinating agents followed by selective methylation and amination. These synthetic strategies allow for high yields and purity, making them suitable for industrial-scale production.

In terms of pharmaceutical development, 4-Amino-5-chloro-2-methoxybenzoic acid serves as a valuable intermediate in the synthesis of more complex drug molecules. Its structural framework can be modified through further functionalization to create novel compounds with enhanced pharmacological properties. For instance, replacing or adding other substituents can alter its binding affinity to specific targets or improve its metabolic stability. This flexibility makes it an indispensable tool in medicinal chemistry.

The safety profile of 4-Amino-5-chloro-2-methoxybenzoic acid is another important consideration in its application as a pharmaceutical intermediate. Preclinical studies have been conducted to assess its toxicity and potential side effects. These studies have generally shown that the compound is well-tolerated at moderate doses, although further research is needed to fully understand its long-term effects. As with any chemical substance used in drug development, careful consideration must be given to dosage regimens and potential interactions with other drugs.

The future prospects for 4-Amino-5-chloro-2-methoxybenzoic acid are promising, with ongoing research exploring new therapeutic applications and synthetic methodologies. Advances in computational chemistry and high-throughput screening technologies are expected to accelerate the discovery of novel derivatives with improved pharmacological profiles. Additionally, collaborations between academic institutions and pharmaceutical companies will likely drive innovation in this field.

In conclusion,4-Amino-5-chloro-2-methoxybenzoic acid (CAS No. 7206-70-4) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique structural features make it a valuable scaffold for targeting various diseases, including inflammation, cancer, and infections. With continued research efforts focused on optimizing its synthesis and exploring new applications,this compound is poised to make substantial contributions to modern medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)